LGALS9 and cancer: Circulating levels of Gal-9 serve as sensitive and non-invasive biomarkers in a broad range of conditions, including cancer, autoimmunity, and infectious diseases, and the roles of Gal-9 vary with respect to cell type and disease state (Moar and Tandon, 2021).